BCM
BLFS icon

BlueCrest Capital Management’s BioLife Solutions BLFS Stock Holding History

BlueCrest Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,290
Closed -$291K – 476
2019
Q1 		$291K Buy
16,290
+4,696
+41% +$74.7K 0.01% 723
2018
Q4 		$139K Buy
+11,594
New +$138K 0.01% 722

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BlueCrest Capital Management's BLFS Position: Q2 2019 in Review

BlueCrest Capital Management sold out of BioLife Solutions (BLFS) in Q2 2019, closing a stake of 16,290 shares — an estimated $291K sold.

BlueCrest Capital Management first reported a position in BLFS in Q4 2018 and held it in 2 quarters. The position peaked at $291K in Q1 2019. 73 funds tracked by Wall St. Rank hold BLFS as of Q2 2019.

  • BlueCrest Capital Management reported no remaining BioLife Solutions position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 16,290 BioLife Solutions shares in Q2 2019, an estimated $291K.
  • BlueCrest Capital Management first reported a position in BioLife Solutions in Q4 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's BioLife Solutions position peaked at $291K in Q1 2019.
  • 73 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.